ViCentra announced today that it made its Kaleido automated insulin pump immediately available, with no waiting period to get ...

MiniMed Chief Product and Technology Officer Ali Dianaty explains how the company developed its latest automated insulin ...

Insulet Corp. (NASDAQ:PODD) is one of the 7 oversold stocks to buy with double-digit ROE growth. On April 6, Evercore ISI ...

Damiano, a professor at Boston University and the chief executive of a promising start-up called Beta Bionics, was there to support a new generation of continuous glucose monitoring technology – part ...

Advanced report intelligence delivers actionable guidance to improve outcomes for people using the iLet Bionic PancreasIRVINE, Calif., March 31, 2026 (GLOBE NEWSWIRE) -- Beta Bionics today announced ...

Irvine-based Beta Bionics, which recently went public, saw two-year revenue increase more than eight-fold to $103.2 million.

An insulin pump emitting a high-pitched noise from inside a garbage can early Monday drew an emergency response from the New Jersey State Police Bomb Squad and led to several evacuations, authorities ...

A bipartisan quartet of of senators on Wednesday unveiled legislation to cap the monthly cost of insulin at $35 for patients on private insurance. Sens. Jeanne Shaheen (D-N.H.), Susan Collins (R-Maine ...

A bipartisan group of senators is resurfacing legislation to cap many American patients’ insulin costs at $35 a month — the INSULIN Act of 2026 — reviving a push that previously stalled. The bill, ...

There's a problem with obesity drug trials: patients often can quickly tell if they're on placebo and drop out to get an effective treatment. (Bloomberg via MSN) The FDA cleared the MiniMed Flex, a ...

MiniMed is out to prove it deserves the name, with a new FDA clearance for its smallest insulin pump yet. At about half the size of the company’s mainstay 780G pump, the MiniMed Flex is described as ...

Minimed Group Inc. secured U.S. FDA approval for Minimed Flex, its next-generation discreet, smartphone-controlled insulin pump. The nod from the FDA follows the company’s debut on Nasdaq March 6.